Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the pharma industry. This time, you get to discover five hand-picked startups offering pharmacology solutions.
Out of 1 268, the Global Startup Heat Map highlights 5 Top Pharmacology Solutions
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 1 268 exemplary startups & scaleups we analyzed for this research. Further, it highlights five pharma startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these five startups & scaleups in this report. For insights on the other 1 263 pharmacology solutions, get in touch with us.
Antiverse advances AI-based Drug Discovery
Founding Year: 2017
Location: Cardiff, UK
Funding: USD 2,43 M
Innovative with Antiverse for Binder Recovery & Customization
UK-based startup Antiverse uses machine learning to optimize the drug discovery process. The startup’s solution uses deep sequencing and computational techniques to select DNA sequences that would otherwise be missed. These sequences are clustered based on their binding score that is assigned according to the similarity of sequence behavior, providing a greater understanding of the disease. Antiverse’s method thus allows access to multiple drug formulations while requiring less time in comparison to traditional methods.
Dalriada enables Small Molecule Discovery
Founding Year: 2017
Location: Toronto, Canada
Funding: USD 100 000
Partner with Dalriada for Accelerated Drug Discovery
Canadian startup Dalriada advances small molecule drug discovery. It specializes in Target-to-IND stage drug discovery projects on small molecule development. The startup facilitates drug development in immuno-oncology, inflammation and immunology, cardiovascular and metabolic diseases, neuroscience, and anti-infectives. This approach minimizes turn-around times, allows full customization of R&D, and improves partner engagement.
Epiodyne enhances Receptor Pharmacology
Founding Year: 2016
Location: San Francisco, US
Funding: USD 14,3 M
Use this solution for Analgesic Development
Epiodyne is a US-based startup that develops novel analgesics capable of treating neurobehavioral symptoms for brain disorders. The startup’s treatment modulates endorphin signaling and relieves the debilitating symptoms of serious brain disorders. Epiodyne’s technology also aids the determination of high-resolution structures of multiple opioid receptors. This optimizes the activity level of receptor types and mitigates the family and societal impacts of serious mental illness and neurodegenerative diseases.
Apnimed develops Sleep Apnea Cure
Founding Year: 2017
Location: Cambridge, US
Funding: USD 65,6 M
Partner with Apnimed for Sleep Disorder Treatment
US-based pharma startup Apnimed makes oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders. The startup’s proprietary approach studies the key underlying neurobiological mechanisms and designs therapies that target the irregularities that lead to airway obstruction. The startup’s drug candidate, AD109, targets two neurochemical pathways that control the upper airway musculature during sleep. The medicine’s dual mechanism of action leads to upper airway dilation and improved respiration and oxygenation during sleep. This approach substantially improves the treatment of patients with symptomatic snoring.
FOx Biosystems facilitates Therapeutic Drug Monitoring
Founding Year: 2016
Location: Diepenbeek, Belgium
Funding: USD 2,19 M
Use this solution for Biomolecular Interaction Analysis
FOx Biosystems is a Belgian startup that develops a proprietary technology that uses the surface plasmon resonance (SPR) principle for biomolecular interaction analysis. The startup’s eponymous solution offers an accurate, fast, and convenient alternative to techniques currently used for therapeutic drug monitoring. Its biosensors accurately detect, quantify and measure the potency of the antibody of interest in a variety of sample matrices. This enables researchers to generate high-quality, cost-effective biomolecular data accurately and over a wide range of applications.
Discover more Pharma Startups
Pharma startups such as the examples highlighted in this report focus on proteomics, drug development, bioinformatics as well as deep learning, AI, and machine learning. While all of these technologies play a major role in advancing the pharma industry, they only represent the tip of the iceberg. To explore pharma technologies in more detail, simply let us look into your areas of interest. For a more general overview, download our free Pharma Innovation Report to save your time and improve strategic decision-making.
